MedPath
Found 4 clinical trials|View Analysis
Sort by:

Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors

Phase 1
Not yet recruiting
Conditions
Solid Tumor
Interventions
Drug: NP-101
First Posted Date
2024-08-20
Last Posted Date
2024-10-04
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
35
Registration Number
NCT06563375
Locations
๐Ÿ‡บ๐Ÿ‡ธ

MD Anderson Cancer Center, Houston, Texas, United States

Study of NP-101 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Undergoing Y-90 Treatment

Phase 1
Not yet recruiting
Conditions
Hepatocellular Carcinoma
Interventions
Drug: NP-101 (3 g)
Drug: NP-101 (4.8 g)
Drug: NP-101 (6 g)
First Posted Date
2024-01-22
Last Posted Date
2024-12-13
Lead Sponsor
University of Florida
Target Recruit Count
18
Registration Number
NCT06217094
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Florida, Gainesville, Florida, United States

Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.

Phase 2
Recruiting
Conditions
COVID-19
Interventions
Drug: NP-101
Other: Placebo
First Posted Date
2023-03-27
Last Posted Date
2024-07-22
Lead Sponsor
Novatek Pharmaceuticals
Target Recruit Count
308
Registration Number
NCT05785390
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Pearland Family Wellness Clinic, Pearland, Texas, United States

๐Ÿ‡บ๐Ÿ‡ธ

L&A Morales Healthcare/ Enrique Villa, MD Principal Investigator, Miami, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

Clinical Trial Network, Houston, Texas, United States

and more 1 locations

NP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine Carcinomas

Phase 1
Active, not recruiting
Conditions
Gastroenteropancreatic Neuroendocrine Tumor
Mixed Neuroendocrine-Non Neuroendocrine Neoplasm
Gastroenteropancreatic Neuroendocrine Neoplasm
Neuroendocrine Carcinoma
Interventions
First Posted Date
2022-03-02
Last Posted Date
2024-05-24
Lead Sponsor
Amr Mohamed MD
Target Recruit Count
15
Registration Number
NCT05262556
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath